<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Fortis Frontier Plc — News on 6ix</title>
    <link>https://6ix.com/company/fortis-frontier-plc</link>
    <description>Latest news and press releases for Fortis Frontier Plc on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 05 May 2026 06:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/fortis-frontier-plc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d57e8dbeedb30cb6f89a8b.webp</url>
      <title>Fortis Frontier Plc</title>
      <link>https://6ix.com/company/fortis-frontier-plc</link>
    </image>
    <item>
      <title>Update</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/update-87</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/update-87</guid>
      <pubDate>Tue, 05 May 2026 06:00:00 GMT</pubDate>
      <description>Fortis Frontier PLC will be suspended from trading on AIM effective 7:30 am on May 11, 2026, as it will not complete a reverse takeover by the May 10 deadline, in accordance with AIM Rule 15. The company, which had approximately £3.7 million in cash as of April 30, 2026, is actively seeking acquisition opportunities to enhance shareholder value. If a suitable acquisition is not completed by November 11, 2026, leading to a potential cancellation of admission under AIM Rule 41, the directors will </description>
    </item>
    <item>
      <title>Transaction in Own Shares &amp; TVR</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/transaction-in-own-shares-and-tvr-21</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/transaction-in-own-shares-and-tvr-21</guid>
      <pubDate>Fri, 01 May 2026 06:00:00 GMT</pubDate>
      <description>Fortis Frontier PLC announced a transaction in its own shares, purchasing 1,600,000 ordinary shares at 8.6 pence each on April 30, 2026, representing approximately 4.43% of its issued share capital. These shares are intended for cancellation, which will reduce the total number of ordinary shares in issue to 34,548,766. This new figure will serve as the denominator for shareholders calculating their notification requirements under the FCA&apos;s Disclosure Guidance and Transparency Rules.
            </description>
    </item>
    <item>
      <title>Transaction in Own Shares and Total Voting Rights</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/transaction-in-own-shares-and-total-voting-rights-59</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/transaction-in-own-shares-and-total-voting-rights-59</guid>
      <pubDate>Thu, 16 Apr 2026 06:00:00 GMT</pubDate>
      <description>Fortis Frontier PLC announced the purchase of 100,000 ordinary shares at 8.6 pence per share, representing approximately 0.19% of its issued share capital, with the intention to cancel these shares. Following this transaction, the Company&apos;s total number of ordinary shares in issue will be 51,500,827, which shareholders should use as the denominator for calculating their notifiable interests under FCA rules.
                Disclaimer*</description>
    </item>
    <item>
      <title>Holding(s) in Company</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/holdings-in-company-1240</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/holdings-in-company-1240</guid>
      <pubDate>Fri, 10 Apr 2026 10:04:00 GMT</pubDate>
      <description>Jonathan David Selby Cranston has acquired a new holding in Fortis Frontier PLC, crossing a notification threshold on April 9, 2026. Following this acquisition, he now holds 1,591,500 ordinary shares, representing 3.084% of the company&apos;s voting rights. This notification indicates a change in substantial shareholding within the issuer.
                Disclaimer*</description>
    </item>
    <item>
      <title>Publication of Circular, RPT and Notice of GM</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/publication-of-circular-rpt-and-notice-of-gm</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/publication-of-circular-rpt-and-notice-of-gm</guid>
      <pubDate>Wed, 01 Apr 2026 06:00:00 GMT</pubDate>
      <description>Fortis Frontier PLC has announced a related party transaction involving the purchase of 13,717,619 ordinary shares from Mercia at 9.0 pence per share, for a total cost of approximately £1,234,586, funded by surplus cash. This transaction requires approval from independent shareholders via ordinary resolutions at a general meeting scheduled for 28 April 2026. The Directors believe this buyback is in the best interests of the company and its shareholders, representing a good and value-enhancing us</description>
    </item>
    <item>
      <title>Final Results</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/final-results-745</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/final-results-745</guid>
      <pubDate>Thu, 19 Mar 2026 07:00:00 GMT</pubDate>
      <description>Fortis Frontier PLC has released its audited final results for the year ended 31 December 2025, announcing the disposal of Concepta Diagnostics Limited for £2.375 million. The company&apos;s net assets now stand at £5,381,000, primarily consisting of cash, and it is classified as an AIM Rule 15 cash shell. The total comprehensive loss for the year was £1,627,000, with a basic loss per share of 3.14p. The company is currently evaluating strategic options to maximize shareholder value, including potent</description>
    </item>
    <item>
      <title>Transaction in Own Shares, TVR &amp; Corp Broker Appt</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/transaction-in-own-shares-tvr-and-corp-broker-appt</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/transaction-in-own-shares-tvr-and-corp-broker-appt</guid>
      <pubDate>Mon, 09 Feb 2026 07:00:00 GMT</pubDate>
      <description>Fortis Frontier PLC announced the purchase of 85,000 ordinary shares at 8.0p each, representing approximately 0.16% of its issued share capital, with the intention to cancel these shares, reducing the total number of shares in issue to 51,600,827. This updated figure will serve as the denominator for shareholders calculating their notification requirements under FCA rules. Additionally, the company has appointed Singer Capital Markets as its new Corporate Broker, effective immediately, while Spa</description>
    </item>
    <item>
      <title>Executive Chairman buys 50,000 shares</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/executive-chairman-buys-50000-shares</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/executive-chairman-buys-50000-shares</guid>
      <pubDate>Mon, 05 Jan 2026 13:31:00 GMT</pubDate>
      <description>Fortis Frontier PLC announced that its Executive Chairman, Adam Reynolds, purchased 50,000 ordinary shares at 8.5 pence per share on January 5, 2026, increasing his total interest to 750,886 shares, representing approximately 1.44% of the issued share capital. Additionally, Mr. Reynolds surrendered options for 66,667 ordinary shares with a 52.5p exercise price for nil consideration. This transaction, along with the surrender of options, could be viewed positively by the market as a sign of insid</description>
    </item>
    <item>
      <title>Directorate changes</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/directorate-changes-178</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/directorate-changes-178</guid>
      <pubDate>Tue, 25 Nov 2025 11:06:00 GMT</pubDate>
      <description>Fortis Frontier PLC, formerly MyHealthChecked PLC, announced the resignation of Non-executive Directors Neil Mesher, Lyn Rees, and Amber Vodegel, effective November 30, 2025, following the disposal of its trading subsidiary Concepta Diagnostics Limited. As an AIM Rule 15 cash shell, the company is now focused on right-sizing its board and evaluating strategic options to maximize shareholder value.
                Disclaimer*</description>
    </item>
    <item>
      <title>Myhealthchecked</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/myhealthchecked</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/myhealthchecked</guid>
      <pubDate>Mon, 10 Nov 2025 17:30:00 GMT</pubDate>
      <description>Myhealthchecked (UK) will be deleted from the FTSE AIM All-Share Index effective from the start of trading on November 13, 2025, due to its reclassification as an AIM Rule 15 cash shell. This change impacts its inclusion in the FTSE UK Index Series.
                Disclaimer*</description>
    </item>
    <item>
      <title>Result of General Meeting</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/result-of-general-meeting-368</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/result-of-general-meeting-368</guid>
      <pubDate>Tue, 04 Nov 2025 13:47:00 GMT</pubDate>
      <description>MyHealthChecked PLC announced that shareholders at its General Meeting on November 4, 2025, overwhelmingly approved the disposal of Concepta Diagnostics Limited. The sole resolution passed with 21,657,827 votes, representing 95.85% of shares voted, while 936,672 votes, or 4.15%, were cast against. This strong shareholder endorsement for the strategic divestment is expected to lead to the disposal&apos;s completion shortly, with a subsequent announcement to follow, potentially impacting the company&apos;s </description>
    </item>
    <item>
      <title>Proposed Sale of Concepta Diagnostics Limited</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/proposed-sale-of-concepta-diagnostics-limited</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/proposed-sale-of-concepta-diagnostics-limited</guid>
      <pubDate>Tue, 14 Oct 2025 07:00:00 GMT</pubDate>
      <description>MyHealthChecked PLC has agreed to conditionally sell its subsidiary, Concepta Diagnostics Limited, to Boots UK Limited for £2.375 million, pending shareholder approval. Upon completion, MyHealthChecked is expected to become an AIM Rule 15 cash shell with approximately £5.7 million in unaudited cash balances after expenses. The company intends to change its name following the disposal. Fortis posted an operating loss of £1.69 million on turnover of £3.6 million for the year ended 31 December 2024</description>
    </item>
    <item>
      <title>Half-year Report</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/half-year-report-759</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/half-year-report-759</guid>
      <pubDate>Fri, 26 Sep 2025 06:00:00 GMT</pubDate>
      <description>MyHealthChecked PLC reported unaudited half-year results, revealing revenue of £0.5 million, down from £0.9 million in H1 2024 and £3.6 million for the full year 2024; however, the wellness portfolio experienced a 60% increase compared to H1 2024. The adjusted EBITDA loss was £1.23 million, slightly higher than the £1.199 million loss in H1 2024, but less than the £1.927 million loss for the full year 2024. Cash balances stood at £5.06 million, a decrease from £6.05 million in H1 2024 but still </description>
    </item>
    <item>
      <title>Result of AGM</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/result-of-agm-1158</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/result-of-agm-1158</guid>
      <pubDate>Thu, 31 Jul 2025 13:30:00 GMT</pubDate>
      <description>Result of AGM.</description>
    </item>
    <item>
      <title>Partnership agreement with Patients Know Best</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/partnership-agreement-with-patients-know-best</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/partnership-agreement-with-patients-know-best</guid>
      <pubDate>Wed, 23 Jul 2025 06:00:00 GMT</pubDate>
      <description>Partnership agreement with Patients Know Best.</description>
    </item>
    <item>
      <title>Supply agreement with Boots for own-branded tests</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/supply-agreement-with-boots-for-own-branded-tests</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/supply-agreement-with-boots-for-own-branded-tests</guid>
      <pubDate>Thu, 17 Jul 2025 06:00:00 GMT</pubDate>
      <description>Supply agreement with Boots for own-branded tests.</description>
    </item>
    <item>
      <title>Potential VAT reclaim – update</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/potential-vat-reclaim-update</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/potential-vat-reclaim-update</guid>
      <pubDate>Fri, 25 Apr 2025 06:00:00 GMT</pubDate>
      <description>Potential VAT reclaim – update.</description>
    </item>
    <item>
      <title>Phlebotomy tests registered in the UK and EU</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/phlebotomy-tests-registered-in-the-uk-and-eu</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/phlebotomy-tests-registered-in-the-uk-and-eu</guid>
      <pubDate>Tue, 14 Jan 2025 07:00:00 GMT</pubDate>
      <description>Phlebotomy tests registered in the UK and EU.</description>
    </item>
    <item>
      <title>Exercise of Options</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/exercise-of-options-122</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/exercise-of-options-122</guid>
      <pubDate>Mon, 23 Dec 2024 11:56:00 GMT</pubDate>
      <description>Exercise of Options.</description>
    </item>
    <item>
      <title>Notice of Results</title>
      <link>https://6ix.com/company/fortis-frontier-plc/news/notice-of-results-430</link>
      <guid isPermaLink="true">https://6ix.com/company/fortis-frontier-plc/news/notice-of-results-430</guid>
      <pubDate>Thu, 12 Sep 2024 06:00:00 GMT</pubDate>
      <description>Notice of Results.</description>
    </item>
  </channel>
</rss>